Your search history is turned on.
Date: April 9, 2024 Jurisdictions: Alberta, British Columbia, Manitoba, New Brunswick, All Jurisdictions, Nova Scotia, North West Territories, Nunavut, Ontario, Price Edward Island, Saskatchewan, Yukon
PMN news release 040924 ProMIS Neurosciences Publishes in the Journal of Biological Chemistry on the Interaction Between Pathogenic Proteins as a Treatment Target for ALS Study results support ProMIS TDP-43 misfolding-specific epitope as a potential therapeutic target for Amyotrophic Lateral Sclerosis (ALS) CAMBRIDGE, Massachusetts and TORONTO, Ont...
Date: April 4, 2024 Jurisdictions: Alberta, British Columbia, Manitoba, New Brunswick, All Jurisdictions, Nova Scotia, North West Territories, Nunavut, Ontario, Price Edward Island, Saskatchewan, Yukon
PMN news release 040424 ProMIS Neurosciences to Present in Upcoming Investor Conferences in April CAMBRIDGE, Massachusetts and TORONTO, Ontario April 4, 2024 ProMIS Neurosciences Inc. (Nasdaq: PMN), a biotechnology company focused on the generation and development of therapeutics targeting toxic misfolded proteins in neurodegenerative diseases, today annou...
Date: April 2, 2024 Jurisdictions: Alberta, British Columbia, Manitoba, New Brunswick, All Jurisdictions, Nova Scotia, North West Territories, Nunavut, Ontario, Price Edward Island, Saskatchewan, Yukon
EDGAR PDF Table of Contents PROSPECTUS SUPPLEMENT Filed Pursuant to Rule 424(b)(5) (To prospectus supplement dated January 5, 2024 To Prospectus dated September 29, 2023) Registration No. 333-274658 PROMIS NEUROSCIENCES INC. Up to $13,580,895 Common Shares This prospectus supplement amends and supplements the information in the prospectus, dated S...
Date: April 1, 2024 Jurisdictions: Alberta, British Columbia, Manitoba, New Brunswick, All Jurisdictions, Nova Scotia, North West Territories, Nunavut, Ontario, Price Edward Island, Saskatchewan, Yukon
EDGAR PDF Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 OR TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For The Transi...
PMN CFO F1 040124 Exhibit 31.2 CERTIFICATIONS I, Daniel Geffken, certify that: 1. I have reviewed this annual report on Form 10-K for the year ended December 31, 2023 of ProMIS Neurosciences Inc. (the registrant); 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact...
Date: April 1, 2024 Jurisdictions: Alberta, Ontario
Create participation fee form FORM 13-502F1 CLASS 1 AND CLASS 3B REPORTING ISSUERS PARTICIPATION FEE MANAGEMENT CERTIFICATION I, WARMA, Neil, an officer of the reporting issuer noted below have examined this Form 13-502F1 (the Form) being submitted hereunder to the Ontario Securities Commission and certify that to my knowledge, having exercised reasonable d...
PMN CEO F1 040124 Exhibit 31.1 CERTIFICATIONS I, Neil Warma, certify that: 1. I have reviewed this annual report on Form 10-K for the year ended December 31, 2023 of ProMIS Neurosciences Inc. (the registrant); 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact nece...
Create participation fee form Note: [01 Mar 2017] The following is a consolidation of 13-501F1. It incorporates amendments to this document that came into effect on March 1, 2017. This consolidation is provided for your convenience and should not be relied on as authoritative. FORM 13-501F1 CLASS 1 REPORTING ISSUERS AND CLASS 3B REPORTING ISSUERS PARTICIPATI...